Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2005
09/29/2005WO2005090580A1 Using nonhuman animal model, method of measuring transcription activity, method of measuring cell quantity and method of measuring tumor volume
09/29/2005WO2005090574A1 Vascular endothelial growth inhibiting gene
09/29/2005WO2005090564A1 Gene promoting vascular endothelial cell growth
09/29/2005WO2005090562A1 Sequence capable of accelerating gene expression at moderately low temperature
09/29/2005WO2005090558A1 Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
09/29/2005WO2005090557A1 Method of proliferating pluripotent stem cell
09/29/2005WO2005090556A1 Novel method of acquiring/sustaining stem cell/precursor cell
09/29/2005WO2005090555A1 Methods for purification of cells based on product secretion
09/29/2005WO2005090554A1 Multicellular organisms derived from normal/nondiseased and diseased mammalian tissues
09/29/2005WO2005090550A1 Method of proliferating stem cell
09/29/2005WO2005090549A1 Cell culture microwell
09/29/2005WO2005090368A1 Synthetic membrane anchors
09/29/2005WO2005089520A2 Methods and compositions relating to neuronal cell and tissue differentiation
09/29/2005WO2005089503A2 Cd4-igg2 formulations
09/29/2005WO2005089420A2 Expansion of neural stem cells with lif
09/29/2005WO2005089285A2 Methods and constructs for expressing polypeptide multimers in eukaryotic cells using alternative splicing
09/29/2005WO2005089127A2 Polymer-ceramic-hydrogel composite scaffold for osteochondral repair
09/29/2005WO2005089043A2 Prostate stem cell
09/29/2005WO2005067620A3 ANTIBODIES TO MAdCAM
09/29/2005WO2005063801A3 Method for decreasing the contact between hepta-repeat region s of the corona-virus spike proteins and use thereof
09/29/2005WO2005054440A3 A biomimetic composition reinforced by a polyelectrolytic complex of hyaluronic acid and chitosan
09/29/2005WO2005046616A3 Viral propagation system and uses thereof
09/29/2005WO2005042730A3 Method and system for preparing stem cells from fat tissue
09/29/2005WO2005014787A3 Genetic elements conferring flower petal-specific transgene expression
09/29/2005WO2005007674A3 Anti-human vitronectin antibody and methods for making the same
09/29/2005WO2005003335A9 Rapamycin resistant t cells and therapeutic uses thereof
09/29/2005WO2005003295A3 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds
09/29/2005WO2004113552A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
09/29/2005WO2004093658A3 Improved methods and solutions for storing donor organs
09/29/2005WO2004089302A3 Posh polypeptides, complexes and related methods
09/29/2005WO2004073609A3 Posh associated kinases and related methods
09/29/2005WO2004014314A3 Methods and compositions concerning poxviruses and cancer
09/29/2005WO2003076469A9 Antibodies derived rom anti ed-b l19 and targeting tumor vasculature
09/29/2005US20050216971 DNA having a nucleotide sequence encoding insecticidal proteins; chimeric genes and host cells and plants containing them
09/29/2005US20050216964 Using swine organs devoid of porcine endogenous retrovirus (PERV) for xenotransplantation and treatment of end-stage organ diseases
09/29/2005US20050216959 Using biobolistic electric discharge particle acceleration to transfer gold coated beads into cells; improving heterologous gene transfer and expression
09/29/2005US20050215766 Allergen from mugwort pollen
09/29/2005US20050215509 Method for inhibiting jnk-1 kinase activity by SCCA
09/29/2005US20050215502 Regulation of endogenous gene expression in cells using zinc finger proteins
09/29/2005US20050215467 Multimeric Apo A-I agonist compounds
09/29/2005US20050214942 Activation and expansion of cells
09/29/2005US20050214941 Expansion of neural stem cells with LIF
09/29/2005US20050214940 Nervous system progenitor cell culure for use in treatment and prevention neural degenerative, spinal cord and brain disorders
09/29/2005US20050214939 Direct differentiation method for making cardiomyocytes from human emberyonic stem cells
09/29/2005US20050214938 Stem cell culture comprising cell expressing cardiac troponin, myosin heavy chain and atrial natriuretic factor for use in treatment and prevention of heart disease; regenerative medicine; tissue engineering
09/29/2005US20050214937 Surface proteins of leptospira
09/29/2005US20050214921 BGL3 beta-glucosidase and nucleic acids encoding the same
09/29/2005US20050214910 Chordin-like molecules and uses thereof
09/29/2005US20050214906 Means and methods for regulating gene expression
09/29/2005US20050214896 Method for synthesis of aryl-carotenoids
09/29/2005US20050214873 Monoclonal antibody for use in classification and identification of embryonic connective tissue progenitor cells; regenerative medicine
09/29/2005US20050214872 Antibodies isolating and/or identifying neuronal stem cells and method for isolating and/or identifying neuronal progenitor cells
09/29/2005US20050214867 Prion protein standard and method of making same
09/29/2005US20050214861 Human hematopoietic stem and progenitor antigen and methods for its use
09/29/2005US20050214856 Nucleotide sequences coding bone morphogenic protein for identifying modulators for treatment of bone diseases
09/29/2005US20050214851 Linearized vector for heterologus gene transfer, control and expression
09/29/2005US20050214846 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/29/2005US20050214845 Small and intermediate conductance, calcium-activated potassium channels and uses thereof
09/29/2005US20050214844 Nucleotide sequences coding translocation protein for use in identifying modulators for prevention and treatment of cell proliferative ,inflammatory and autoimmune disorders
09/29/2005US20050214837 Antibody specific for mutant presenilin 1 and method of use thereof
09/29/2005US20050214830 Recombinant g protein coupled receptor for use in identifying modulators for prevention and treatment of cell proliferative disorders
09/29/2005US20050214819 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/29/2005US20050214795 Polypeptide for use as diagnostic indicator of cell proliferative disorders; immunotherapeutics; antitumor agents
09/29/2005US20050214794 Alstroem syndrome gene, gene variants, expressed protein and methods of diagnosis for alstroem syndrome
09/29/2005US20050214774 Isolated monkey cathepsin S proteins, nucleic acid molecules encoding monkey cathepsin S proteins, and uses thereof
09/29/2005US20050214762 Receptor binding domains of leptin; proteolysis; fusion proteins
09/29/2005US20050214756 Cell visual characteristic-modifying sequences
09/29/2005US20050214753 Detection of nucleic acid hybrids
09/29/2005US20050214734 Cell population provided with identification codes and method of screening cell population
09/29/2005US20050214733 Sperm suspensions for use in insemination
09/29/2005US20050214341 Three dimensional, malleable cell culture; tissue engineering; pluripotent cells
09/29/2005US20050214324 Culturing avian cells permissive for productive replication of the virus in a serum free medium containing a growth factor or an attachment factor, infecting of the cells with the virus, and cultivating in serum free media until progeny virus is produced
09/29/2005US20050214314 Human cytokine receptor
09/29/2005US20050214313 Extracellular domain of CTLA4, with (a) an alanine at position +29 substituted with tyrosine, leucine, tryptophan, or threonine, and (b) a leucine at position +104 substituted with glutamic acid; binds CD80 and/or CD86 with greater avidity; inhibiting graft versus host disease
09/29/2005US20050214306 Surface proteins of leptospira
09/29/2005US20050214301 Antibodies specific for BCR-ABL fusion protein and uses thereof
09/29/2005US20050214293 Containing heavy and light chain complementarity determining region 1,2 and 3 components of amino acid sequences 1-6; reduced immunogenicity; increased affinity and avidity; improved cell culturing
09/29/2005US20050214281 G-protein coupled receptor
09/29/2005US20050214274 T-cells are contacted agents that ligate a cell surface; crosslinking by a second agent attached to a biodegradable supports; T-cells and biodegradable supports are suspended in a medium for parenteral infusion and packaged in container
09/29/2005US20050214269 Induction of beta cell differentiation in human cells
09/29/2005US20050214268 Methods for treating tumors and cancerous tissues
09/29/2005US20050214267 Compositions and methods for controlling insects related to the octopamine receptor
09/29/2005US20050214262 Population of hematopoietic cells, made to exhibit a greater clonogenic potential, engraftment potential, immune system reconstitution potential and/or proportion of CD34+ positive cells by culturing with a transition metal compound that chelates copper such as tetraethylenepentamine
09/29/2005US20050214259 Corneal endothelium-like sheet and method of constructing the same
09/29/2005US20050214256 Expression cassette generated from these sequences; generating an immune response in a subject
09/29/2005US20050214253 Interferon-beta fusion proteins and uses
09/29/2005US20050214252 Chordin-like molecules and uses thereof
09/29/2005US20050214213 Cone snail peptides
09/29/2005US20050214211 Active and/or passive immunization; accurate early stage, localized tumor detection
09/29/2005DE102004062386A1 Monacolin K-Biosynthese-Gene Monacolin K biosynthesis genes
09/29/2005CA2598879A1 Prostate stem cell
09/29/2005CA2563345A1 Follicle stimulating hormone superagonists
09/29/2005CA2560581A1 Pluripotent stem cell growing method
09/29/2005CA2560220A1 Genetically modified plants expressing p1b-type atpase of the zn+2/co+2/cd+2/pb+2 subclass and their applications in phytoremediation
09/29/2005CA2559936A1 Methods and compositions for using alveolar macrophage phospholipase a2
09/29/2005CA2559854A1 Method for making high purity cardiomyocyte preparations suitable for regenerative medicine
09/29/2005CA2559840A1 Prostatic acid phosphatase antigens
09/29/2005CA2559736A1 Methods for purification of cells based on product secretion
09/29/2005CA2559721A1 Expansion of neural stem cells with lif
09/29/2005CA2559453A1 Methods and apparatus for integrated cell handling and measurements
1 ... 965 966 967 968 969 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 ... 1827